Payment overview · 2025
General Payments
$20,052.61
100 reported records · 18 companies
Healthcare provider profile · identity verified
Juan Ayerdi, MD
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · COLUMBUS, GA · NPI 1275518326
Verified facts
What the public records show
CMS Open Payments records show Juan Ayerdi, MD received $20,052.61 in general payments during 2025 across 100 reported records.
Endologix LLC accounted for 78.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 30 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Endologix LLC | Unresolved — no canonical attribution shown | $15,820.68 | 78.9% | 49 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $2,513.92 | 12.5% | 19 | 2025 |
| Cook Incorporated | Unresolved — no canonical attribution shown | $623.76 | 3.1% | 2 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $488.52 | 2.4% | 6 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$166.78 | 0.8% | 4 | 2025 |
| Mozarc Medical US LLC | Unresolved — no canonical attribution shown | $87.86 | 0.4% | 4 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $80.17 | 0.4% | 3 | 2025 |
| Becton, Dickinson and Company | Unresolved — no canonical attribution shown | $55.12 | 0.3% | 1 | 2025 |
| LeMaitre Vascular, Inc. | Unresolved — no canonical attribution shown | $47.05 | 0.2% | 2 | 2025 |
| Solventum Corporation | Unresolved — no canonical attribution shown | $23.56 | 0.1% | 1 | 2025 |
| Inari Medical, Inc. | Unresolved — no canonical attribution shown | $23.37 | 0.1% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $23.21 | 0.1% | 1 | 2025 |
| InspireMD Ltd | Unresolved — no canonical attribution shown | $22.10 | 0.1% | 1 | 2025 |
| Neuros Medical, Inc. | Unresolved — no canonical attribution shown | $21.34 | 0.1% | 1 | 2025 |
| PolyNovo North America LLC | Unresolved — no canonical attribution shown | $17.08 | 0.1% | 1 | 2025 |
| Kerecis Limited | Unresolved — no canonical attribution shown | $16.79 | 0.1% | 1 | 2025 |
| Reflow Medical Inc | Unresolved — no canonical attribution shown | $14.48 | 0.1% | 2 | 2025 |
| Flowphysix Inc | Unresolved — no canonical attribution shown | $6.82 | 0.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $10,137.90 | 84 |
| Consulting Fee | $7,800.00 | 10 |
| Travel and Lodging | $2,114.71 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AFX2 Bifurcated Endograft System Normalized: afx2 bifurcated endograft system |
Device | Endologix LLC | $14,125.02 | 41 | 2025 |
Source payment records
|
|||||
| Alto Abdominal Stent Graft System Normalized: alto abdominal stent graft system |
Device | Endologix LLC | $2,421.47 | 7 | 2025 |
Source payment records
|
|||||
| EkoSonic Normalized: ekosonic |
Device | Boston Scientific Corporation | $1,985.20 | 10 | 2025 |
Source payment records
|
|||||
| COOK Normalized: cook |
Device | Cook Incorporated, Cook Medical LLC | $1,112.28 | 8 | 2025 |
Source payment records
|
|||||
| ENROUTE Transcarotid Neuroprotection System Normalized: enroute transcarotid neuroprotection system |
Device | Boston Scientific Corporation | $204.05 | 3 | 2025 |
Source payment records
|
|||||
| General - Vascular Intervention Normalized: general vascular intervention |
Device | Boston Scientific Corporation | $157.74 | 3 | 2025 |
Source payment records
|
|||||
| General - Thrombectomy Normalized: general thrombectomy |
Device | Boston Scientific Corporation | $144.56 | 2 | 2025 |
Source payment records
|
|||||
| PALINDROME Normalized: palindrome |
Device | Mozarc Medical US LLC | $87.86 | 4 | 2025 |
Source payment records
|
|||||
| ABRE Normalized: abre |
Device | Medtronic, Inc. | $85.95 | 1 | 2025 |
Source payment records
|
|||||
| ENDOCROSS Device Normalized: endocross device |
Device | Endologix LLC | $64.78 | 1 | 2025 |
Source payment records
|
|||||
| Torus Stent Graft System Normalized: torus stent graft system |
Device | Endologix LLC | $64.78 | 1 | 2025 |
Source payment records
|
|||||
| ARISTA Normalized: arista |
Device | Becton, Dickinson and Company | $55.12 | 1 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER Normalized: flowtriever |
Device | Stryker Corporation | $53.14 | 2 | 2025 |
Source payment records
|
|||||
| ARTEGRAFT VASCULAR GRAFT Normalized: artegraft vascular graft |
Device | LeMaitre Vascular, Inc. | $31.13 | 1 | 2025 |
Source payment records
|
|||||
| ARTIX MT Normalized: artix mt |
Device | Stryker Corporation | $27.03 | 1 | 2025 |
Source payment records
|
|||||
| HAWKONE Normalized: hawkone |
Device | Medtronic, Inc. | $23.98 | 1 | 2025 |
Source payment records
|
|||||
| PREVENA Normalized: prevena |
Device | Solventum Corporation | $23.56 | 1 | 2025 |
Source payment records
|
|||||
| V.A.C. VERAFLO Normalized: v a c veraflo |
Device | Solventum Corporation | $23.56 | 1 | 2025 |
Source payment records
|
|||||
| V.A.C. VERAFLO CLEANSE CHOICE Normalized: v a c veraflo cleanse choice |
Device | Solventum Corporation | $23.56 | 1 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Inari Medical, Inc. | $23.37 | 1 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Inari Medical, Inc. | $23.37 | 1 | 2025 |
Source payment records
|
|||||
| DIAMONDBACK PERIPHERAL Normalized: diamondback peripheral |
Device | Abbott Laboratories | $23.21 | 1 | 2025 |
Source payment records
|
|||||
| ELUVIA Normalized: eluvia |
Device | Boston Scientific Corporation | $22.37 | 1 | 2025 |
Source payment records
|
|||||
| CGuard Prime Carotid Stent System Normalized: cguard prime carotid stent system |
Device | InspireMD Ltd | $22.10 | 1 | 2025 |
Source payment records
|
|||||
| Altius Normalized: altius |
Device | Neuros Medical, Inc. | $21.34 | 1 | 2025 |
Source payment records
|
|||||
| NOVOSORB BTM Normalized: novosorb btm |
Device | PolyNovo North America LLC | $17.08 | 1 | 2025 |
Source payment records
|
|||||
| Kerecis GraftGuide Normalized: kerecis graftguide |
Device | Kerecis Limited | $16.79 | 1 | 2025 |
Source payment records
|
|||||
| Kerecis SurgiClose Normalized: kerecis surgiclose |
Device | Kerecis Limited | $16.79 | 1 | 2025 |
Source payment records
|
|||||
| HYDRO LEMAITRE VALVULOTOME Normalized: hydro lemaitre valvulotome |
Device | LeMaitre Vascular, Inc. | $15.92 | 1 | 2025 |
Source payment records
|
|||||
| FLOWRUNNER Normalized: flowrunner |
Device | Flowphysix Inc | $6.82 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 195 | 41 |
| Clopidogrel | Clopidogrel Bisulfate | 177 | 55 |
| Cilostazol | Cilostazol | 49 | 14 |
| Xarelto | Rivaroxaban | 48 | 17 |
| Famotidine | Famotidine | 23 | 16 |
| Prednisone | Prednisone | 19 | 15 |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $20,052.61 · 100 records | Endologix LLC | ABRE, AFX2 Bifurcated Endograft System, ARISTA, ARTEGRAFT VASCULAR GRAFT, ARTIX MT, Altius, Alto Abdominal Stent Graft System, CGuard Prime Carotid Stent System, COOK, CT THROMBECTOMY SYSTEM KIT, DIAMONDBACK PERIPHERAL, ELUVIA, ENDOCROSS Device, ENROUTE Transcarotid Neuroprotection System, EkoSonic, FLOWRUNNER, FLOWTRIEVER, FLOWTRIEVER CATHETER, S, General - Thrombectomy, General - Vascular Intervention, HAWKONE, HYDRO LEMAITRE VALVULOTOME, Kerecis GraftGuide, Kerecis SurgiClose, NOVOSORB BTM, PALINDROME, PREVENA, Torus Stent Graft System, V.A.C. VERAFLO, V.A.C. VERAFLO CLEANSE CHOICE | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error